Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, HEALTH CATALYST, INC. reported revenue of $311M, up 1.5% year over year. Operating margin was -51.7% and net margin -57.2%, on a free-cash-flow margin of -0.1% with capital expenditure at 0.3% of revenue. Every figure is computed directly from HCAT's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $311M | -51.7% | -57.2% |
| FY2024 | $307M | -22.8% | -22.7% |
| FY2023 | $296M | -42.9% | -39.9% |
| FY2022 | $276M | -50.7% | -49.7% |
| FY2021 | $242M | -59.4% | -63.3% |
How does HCAT compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: ABM · ACIW · ACN · ACVA · ADBE · ADMQ
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.